M M Lederman|G Schiffman|H M Rodman - JoVE Visualize

Showing results (231-240 of 250) with videos related to

Pageof 25

Sort By:

Nature Communications|August 27, 2021

Oral immune dysfunction is associated with the expansion of FOXP3+PD-1+Amphiregulin+ T cells during HIV infectionN Bhaskaran, E Schneider, F Faddoul, et al.

Nature Communications|January 24, 2023

Polyamine metabolism impacts T cell dysfunction in the oral mucosa of people living with HIVS S Mahalingam, S Jayaraman, N Bhaskaran, et al.

Annals of Internal Medicine|December 1, 1979

Pneumococcal infections after human bone-marrow transplantationD J Winston, G Schiffman, D C Wang, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2001

Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995--1999H Valdez, T K Chowdhry, R Asaad, et al.

The Journal of Infectious Diseases|July 1, 1995

Human immunodeficiency virus (HIV) type 1 infection status and in vitro susceptibility to HIV infection among high-risk HIV-1-seronegative hemophiliacsM M Lederman, J B Jackson, B L Kroner, et al.

Blood|May 9, 2001

A potential role for interleukin-7 in T-cell homeostasisT J Fry, E Connick, J Falloon, et al.

HIV Medicine|May 18, 2016

Systemic inflammation and liver damage in HIV/hepatitis C virus coinfectionK V Shmagel, E V Saidakova, N G Shmagel, et al.

The Journal of Infectious Diseases|March 9, 1999

Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end pointsH Wu, D R Kuritzkes, D R McClernon, et al.

The Journal of Clinical Investigation|July 3, 1998

In vivo analysis of Fas/FasL interactions in HIV-infected patientsA D Badley, D H Dockrell, A Algeciras, et al.

The New England Journal of Medicine|November 20, 1986

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative StudyM S Simberkoff, A P Cross, M Al-Ibrahim, et al.

Pageof 25

Showing results (231-240 of 250) with videos related to

Sort By:

Pageof 25

Nature Communications|August 27, 2021

Oral immune dysfunction is associated with the expansion of FOXP3+PD-1+Amphiregulin+ T cells during HIV infectionN Bhaskaran, E Schneider, F Faddoul, et al.

Nature Communications|January 24, 2023

Polyamine metabolism impacts T cell dysfunction in the oral mucosa of people living with HIVS S Mahalingam, S Jayaraman, N Bhaskaran, et al.

Annals of Internal Medicine|December 1, 1979

Pneumococcal infections after human bone-marrow transplantationD J Winston, G Schiffman, D C Wang, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2001

Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995--1999H Valdez, T K Chowdhry, R Asaad, et al.

The Journal of Infectious Diseases|July 1, 1995

Human immunodeficiency virus (HIV) type 1 infection status and in vitro susceptibility to HIV infection among high-risk HIV-1-seronegative hemophiliacsM M Lederman, J B Jackson, B L Kroner, et al.

Blood|May 9, 2001

A potential role for interleukin-7 in T-cell homeostasisT J Fry, E Connick, J Falloon, et al.

HIV Medicine|May 18, 2016

Systemic inflammation and liver damage in HIV/hepatitis C virus coinfectionK V Shmagel, E V Saidakova, N G Shmagel, et al.

The Journal of Infectious Diseases|March 9, 1999

Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end pointsH Wu, D R Kuritzkes, D R McClernon, et al.

The Journal of Clinical Investigation|July 3, 1998

In vivo analysis of Fas/FasL interactions in HIV-infected patientsA D Badley, D H Dockrell, A Algeciras, et al.

The New England Journal of Medicine|November 20, 1986

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative StudyM S Simberkoff, A P Cross, M Al-Ibrahim, et al.

Pageof 25